INTEC PHARMA LTD JERUSALEM (NTEC)
Institutional ownership reported to the SEC as of Q2 2021, across 11 quarters.
8
Reporting holders
$2.7M
Reported value
0.0%
Held as options
-8
Holder change
Options share is the part of reported value carried in derivative lines rather than shares. A high figure means institutions are expressing a view on this security without owning much of it.
Holders
| Filer | Value | Shares | Their book | Held | Change |
|---|---|---|---|---|---|
| AdvisorShares Investments LLC | $1.5M | 443,008 | 0.21% | 3q | HELD |
| MEITAV DASH INVESTMENTS LTD | $840.0K | 241,982 | 0.01% | 3q | +100.0%+$420.0K |
| MORGAN STANLEY | $121.0K | 34,818 | 0.00% | 3q | +2984.0%+$117.1K |
| GSA CAPITAL PARTNERS LLP | $116.0K | 33,291 | 0.01% | 3q | -29.0%-$47.5K |
| Squarepoint Ops LLC | $67.0K | 19,200 | 0.00% | new | NEW |
| CITADEL ADVISORS LLC | $43.0K | 12,357 | 0.00% | 3q | -44.7%-$34.8K |
| WELLS FARGO & COMPANY/MN | $1.0K | 250 | 0.00% | 3q | -92.3%-$12.0K |
| ADVISOR GROUP HOLDINGS, INC. | $1.0K | 250 | 0.00% | 3q | HELD |
Quarter by quarter
Coverage begins with the quarter ending 2018-12-31. Earlier filings exist only as occasional late amendments, too sparse to describe a market, so they are not shown.
| Quarter | Holders | Value | Shares | New | Added | Trimmed | Options |
|---|---|---|---|---|---|---|---|
| Q2 2021 | 8 | $2.7M | 785,156 | 1 | 2 | 3 | 0.0% |
| Q1 2021 | 16 | $3.6M | 802,331 | 5 | 4 | 3 | 1.7% |
| Q4 2020 | 18 | $1.8M | 493,988 | 19 | 0 | 0 | 4.9% |
| Q3 2020 | 2 | $17.0K | 0 | 1 | 0 | 0 | 100.0% |
| Q2 2020 | 1 | $1.0K | 0 | 1 | 0 | 0 | 100.0% |
| Q1 2020 | 2 | $5.0K | 0 | 1 | 0 | 0 | 100.0% |
| Q4 2019 | 1 | $7.0K | 0 | 0 | 0 | 0 | 100.0% |
| Q3 2019 | 2 | $33.0K | 0 | 0 | 0 | 0 | 100.0% |
| Q2 2019 | 3 | $1.4M | 0 | 1 | 0 | 0 | 100.0% |
| Q1 2019 | 2 | $323.0K | 0 | 1 | 0 | 0 | 100.0% |
| Q4 2018 | 2 | $112.0K | 0 | 0 | 0 | 0 | 100.0% |